DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
DarioHealth Corp. (DRIO), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on August 16, 2021. The filing serves to announce the Company's financial and operating results for the quarter and six months ended June 30, 2021.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K.
Material Changes
No specific material changes versus prior periods are detailed in the text of this filing. The document solely references the attached press release for operational highlights and financial comparisons.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, and specific risk factors are not included in the text of this 8-K. The filing explicitly states that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other documents except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 16, 2021) for actual revenue, net loss, and cash position figures.
- Verify the specific operational highlights and product milestones mentioned in the attached press release.
- Confirm the Company's status as an emerging growth company and any associated accounting election impacts.
- Check subsequent filings for the full audited or reviewed financial statements for the period ended June 30, 2021.